Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;54(1):25.
doi: 10.1186/s41983-018-0026-y. Epub 2018 Sep 15.

Serum insulin-like growth factor 1 (IGF-1) in multiple sclerosis: relation to cognitive impairment and fatigue

Rania S Nageeb  1 , Noha A Hashim  1 , Amal Fawzy  2
Affiliations

Serum insulin-like growth factor 1 (IGF-1) in multiple sclerosis: relation to cognitive impairment and fatigue

Rania S Nageeb et al. Egypt J Neurol Psychiatr Neurosurg. 2018.

Abstract

Background: Multiple sclerosis (MS) is a chronic demyelinating central nervous system (CNS) disease. Changes in insulin growth factor 1 (IGF-1) input to the brain can affect survival of myelin and CNS cells. The study aims to investigate the relation of serum IGF-1 levels with cognitive impairment and fatigue in MS patients.

Methods: This study was conducted on 46 MS patients and 46 healthy controls. All participants were subjected to clinical assessment, serum IGF-1 levels, expanded disability status scale (EDSS), modified fatigue impact scale (MFIS), and Montreal cognitive assessment (MoCA) scale.

Results: There was no significant difference between patients and controls regarding serum IGF-1 levels (P = 0.19). However, low serum levels of IGF-1 have significantly greater odds for fatigue (P = 0.002) and cognitive impairment (P < 0.001). Also, serum IGF-1 levels have a significant negative correlation with MFIS (r = - 0.701 and P < 0.001) and a significant positive correlation with MoCA scale (r = + 0.84 and P < 0.001).

Conclusions: The results, specifically that low levels of serum IGF-1 was associated with cognitive impairment and fatigue in MS, suggest that IGF-I may be involved in the pathogenesis of cognitive deficits and fatigue in MS disease.

Keywords: Cognitive impairment; Fatigue; Insulin-like growth factor-1; Multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

The study was approved from the Institutional Ethics Committee of the Faculty of Medicine, Zagazig University (ZU-IRB#4730\ 24-12-2017). A written consent was taken from all of the participants after explaining the details and benefits as well as risks to them.Consent has been obtained from the participants involved in the study to report their individual patient data.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Correlation coefficient of variables with serum levels of IGF-1 in MS patients
See this image and copyright information in PMC

References

    1. Adamis Dimitrios, Meagher David. Insulin-Like Growth Factor I and the Pathogenesis of Delirium: A Review of Current Evidence. Journal of Aging Research. 2011;2011:1–11. doi: 10.4061/2011/951403. - DOI - PMC - PubMed
    1. Akcali A, Bal B, Erbagci B. Circulating IGF-1, IGFB-3, GH and TSH levels in multiple sclerosis and their relationship with treatment. Neurol Res. 2017;39(7):606–611. doi: 10.1080/01616412.2017.1321711. - DOI - PubMed
    1. Aksoy S, Timer E, Mumcu S, et al. Screening for cognitive impairment in multiple sclerosis with MOCA test. Turkish Journal of Neurology. 2013;19:52–55.
    1. Al-Delaimy WK, von Muhlen D, Barrett-Connor E. IGF-1 and IGFBP-1 and cognitive function in older men and women. J Am Geriatr Soc. 2009;57(8):1441–1446. doi: 10.1111/j.1532-5415.2009.02343.x. - DOI - PMC - PubMed
    1. Allain TJ, Bearn JA, Coskeran P, et al. Changes in growth hormone, insulin, insulin like growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry. 1997;41(5):567–573. doi: 10.1016/S0006-3223(96)00074-1. - DOI - PubMed

LinkOut - more resources